WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 322
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 402

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 10  10  10  10  10  10 
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years
Female 15-49 years

Number of reported case

(Click for retrospective incidence data for Nauru)
Diphtheria
Japanese encephalitis
Measles 11  300  10 
Mumps
Pertussis 166 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Nauru)
Vaccine year result method % card seen                                                
BCG 2006  98  DHS   95.0  100  100  100  100  100  93 
DTP1 2006  98  DHS   95.0  98  100  100  100  100  85 
DTP3 2006  89  DHS   95.0  79  100  100  100  100  44 
HepB_BD          100  100  100  100  100  98 
HepB3          79  100  100  100  100  58 
Hib3          79  100  100  100 
JapEnc         
MCV 2006  95  DHS   95.0  96  100  100  100  100 
MCV2          81  100  100  92  100 
PCV1         
PCV3         
Pol3 2006  91  DHS   95.0  79  100  100  100  100  27 
Rota1         
Rota_last         
Rubella1          96  100  100  100 
TT2plus          100  100  100  34 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Nauru)
BCG 99  99  99  99  99  93  93 
DTP1 98  99  99  99  99  85  90 
DTP3 79  99  99  99  99  44  74 
HepB3 79  99  99  99  99  58 
Hib3 79  99  99  99 
MCV 96  99  99  99  99 
PCV3
Pol3 79  99  99  99  99  27  74 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks;
HepB birth; Yes
MR 12, 15 months; Yes
OPV 6, 10, 14 week; 18 months; 4 years; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR No  No  Yes  No  Yes  No  No 
What years does the MYP cover? number         2008 to 2010    NA 
Nº of districts with microplans that include activities to raise immunization coverage number     14      14 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number 14    14  14 
Nº districts with DTP3 coverage >=80% number        
% of districts with DTP3 coverage >=80% From 0 to 100% 100  50          100 
Nº districts with measles (MCV1) coverage >=95% number       NA     
% of districts with MCV1 coverage >=95% From 0 to 100%          

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR No  No  Yes    No  No  No 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.